S&P 500   3,339.35 (-0.37%)
DOW   27,430.44 (-0.56%)
QQQ   276.24 (-0.35%)
AAPL   114.03 (-0.81%)
MSFT   208.82 (-0.30%)
FB   259.56 (+1.07%)
GOOGL   1,460.05 (+0.10%)
AMZN   3,164.89 (-0.29%)
TSLA   415.76 (-1.29%)
NVDA   523.85 (+0.47%)
BABA   278.01 (+0.72%)
CGC   14.27 (+0.42%)
MU   50.82 (+2.21%)
GE   6.12 (-1.29%)
AMD   80.54 (+1.33%)
T   28.18 (-0.70%)
F   6.61 (-1.20%)
ACB   4.64 (-2.93%)
GILD   62.32 (-0.84%)
NFLX   489.16 (-0.30%)
DIS   124.42 (-1.25%)
BA   163.96 (-1.28%)
BAC   23.71 (-1.58%)
S&P 500   3,339.35 (-0.37%)
DOW   27,430.44 (-0.56%)
QQQ   276.24 (-0.35%)
AAPL   114.03 (-0.81%)
MSFT   208.82 (-0.30%)
FB   259.56 (+1.07%)
GOOGL   1,460.05 (+0.10%)
AMZN   3,164.89 (-0.29%)
TSLA   415.76 (-1.29%)
NVDA   523.85 (+0.47%)
BABA   278.01 (+0.72%)
CGC   14.27 (+0.42%)
MU   50.82 (+2.21%)
GE   6.12 (-1.29%)
AMD   80.54 (+1.33%)
T   28.18 (-0.70%)
F   6.61 (-1.20%)
ACB   4.64 (-2.93%)
GILD   62.32 (-0.84%)
NFLX   489.16 (-0.30%)
DIS   124.42 (-1.25%)
BA   163.96 (-1.28%)
BAC   23.71 (-1.58%)
S&P 500   3,339.35 (-0.37%)
DOW   27,430.44 (-0.56%)
QQQ   276.24 (-0.35%)
AAPL   114.03 (-0.81%)
MSFT   208.82 (-0.30%)
FB   259.56 (+1.07%)
GOOGL   1,460.05 (+0.10%)
AMZN   3,164.89 (-0.29%)
TSLA   415.76 (-1.29%)
NVDA   523.85 (+0.47%)
BABA   278.01 (+0.72%)
CGC   14.27 (+0.42%)
MU   50.82 (+2.21%)
GE   6.12 (-1.29%)
AMD   80.54 (+1.33%)
T   28.18 (-0.70%)
F   6.61 (-1.20%)
ACB   4.64 (-2.93%)
GILD   62.32 (-0.84%)
NFLX   489.16 (-0.30%)
DIS   124.42 (-1.25%)
BA   163.96 (-1.28%)
BAC   23.71 (-1.58%)
S&P 500   3,339.35 (-0.37%)
DOW   27,430.44 (-0.56%)
QQQ   276.24 (-0.35%)
AAPL   114.03 (-0.81%)
MSFT   208.82 (-0.30%)
FB   259.56 (+1.07%)
GOOGL   1,460.05 (+0.10%)
AMZN   3,164.89 (-0.29%)
TSLA   415.76 (-1.29%)
NVDA   523.85 (+0.47%)
BABA   278.01 (+0.72%)
CGC   14.27 (+0.42%)
MU   50.82 (+2.21%)
GE   6.12 (-1.29%)
AMD   80.54 (+1.33%)
T   28.18 (-0.70%)
F   6.61 (-1.20%)
ACB   4.64 (-2.93%)
GILD   62.32 (-0.84%)
NFLX   489.16 (-0.30%)
DIS   124.42 (-1.25%)
BA   163.96 (-1.28%)
BAC   23.71 (-1.58%)
Log in
NYSE:GEN

Genesis Healthcare Stock Forecast, Price & News

$0.54
-0.01 (-0.93 %)
(As of 09/29/2020 10:55 AM ET)
Add
Compare
Today's Range
$0.54
Now: $0.54
$0.55
50-Day Range
$0.58
MA: $0.67
$1.02
52-Week Range
$0.54
Now: $0.54
$1.86
Volume4,244 shs
Average Volume759,759 shs
Market Capitalization$90.54 million
P/E Ratio2.47
Dividend YieldN/A
Beta1.44
Genesis Healthcare, Inc., together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy. In addition, the company offers other specialty medical services, such as physician, staffing, and other healthcare related services. As of December 31, 2018, it provided inpatient services through a network of 425 skilled nursing and assisted/senior living facilities, including 399 skilled nursing facilities and 26 stand-alone assisted/senior living facilities across 29 states. Genesis HealthCare, Inc. also supplies rehabilitation and respiratory therapy to approximately 1,400 healthcare locations in 46 states and the District of Columbia. The company was formerly known as FC-GEN Operations Investment, LLC and changed its name to Genesis HealthCare, Inc. in February 2015. Genesis HealthCare, Inc. was founded in 2003 and is headquartered in Kennett Square, Pennsylvania.
Read More
Genesis Healthcare logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.99 out of 5 stars


Industry, Sector and Symbol

Industry Skilled nursing care facilities
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone610-444-6350

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.57 billion
Cash Flow$0.73 per share
Book Value($6.57) per share

Profitability

Net Income$14.62 million

Miscellaneous

Employees55,000
Market Cap$90.54 million
Next Earnings Date11/5/2020 (Estimated)
OptionableOptionable
$0.54
-0.01 (-0.93 %)
(As of 09/29/2020 10:55 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GEN News and Ratings via Email

Sign-up to receive the latest news and ratings for GEN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Genesis Healthcare (NYSE:GEN) Frequently Asked Questions

How has Genesis Healthcare's stock price been impacted by Coronavirus (COVID-19)?

Genesis Healthcare's stock was trading at $1.16 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, GEN stock has decreased by 53.2% and is now trading at $0.5430.
View which stocks have been most impacted by COVID-19
.

When is Genesis Healthcare's next earnings date?

Genesis Healthcare is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Genesis Healthcare
.

How were Genesis Healthcare's earnings last quarter?

Genesis Healthcare Inc (NYSE:GEN) announced its quarterly earnings results on Monday, August, 10th. The company reported ($0.20) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.32) by $0.12. The company earned $956.26 million during the quarter. Genesis Healthcare had a net margin of 1.07% and a negative return on equity of 5.06%.
View Genesis Healthcare's earnings history
.

Are investors shorting Genesis Healthcare?

Genesis Healthcare saw a drop in short interest in the month of September. As of September 15th, there was short interest totaling 1,550,000 shares, a drop of 16.7% from the August 31st total of 1,860,000 shares. Based on an average trading volume of 984,500 shares, the days-to-cover ratio is presently 1.6 days. Approximately 2.8% of the company's shares are sold short.
View Genesis Healthcare's Short Interest
.

Who are some of Genesis Healthcare's key competitors?

What other stocks do shareholders of Genesis Healthcare own?

Who are Genesis Healthcare's key executives?

Genesis Healthcare's management team includes the following people:
  • Mr. George V. Hager Jr., CEO & Director (Age 63)
  • Mr. Thomas DiVittorio, CFO, Exec. VP, Treasurer & Assistant Sec. (Age 51)
  • Mr. Paul David Bach, COO & Exec. VP (Age 60)
  • Dr. JoAnne Susan Reifsnyder Ph.D., MSN, MBA, FAAN, Exec. VP of Clinical Operations & Chief Nursing Officer (Age 60)
  • Mr. Richard L. Castor, Chief Information Officer & Sr. VP (Age 64)

What is Genesis Healthcare's stock symbol?

Genesis Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "GEN."

How do I buy shares of Genesis Healthcare?

Shares of GEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Genesis Healthcare's stock price today?

One share of GEN stock can currently be purchased for approximately $0.54.

How big of a company is Genesis Healthcare?

Genesis Healthcare has a market capitalization of $90.54 million and generates $4.57 billion in revenue each year. Genesis Healthcare employs 55,000 workers across the globe.

What is Genesis Healthcare's official website?

The official website for Genesis Healthcare is www.genesishcc.com.

How can I contact Genesis Healthcare?

Genesis Healthcare's mailing address is 101 EAST STATE STREET, KENNETT SQUARE PA, 19348. The company can be reached via phone at 610-444-6350 or via email at [email protected]

This page was last updated on 9/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.